Literature DB >> 22993189

Hyperediting of human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 by the dsRNA adenosine deaminase ADAR-1.

Nga Ling Ko1, Emmanuel Birlouez2, Simon Wain-Hobson2, Renaud Mahieux3,1, Jean-Pierre Vartanian2.   

Abstract

RNA editing mediated by adenosine deaminases acting on RNA (ADARs) converts adenosine (A) to inosine (I) residues in dsRNA templates. While ADAR-1-mediated editing was essentially described for RNA viruses, the present work addresses the issue for two δ-retroviruses, human T-cell leukemia virus type 2 and simian T-cell leukemia virus type 3 (HTLV-2 and STLV-3). We examined whether ADAR-1 could edit HTLV-2 and STLV-3 virus genomes in cell culture and in vivo. Using a highly sensitive PCR-based method, referred to as 3DI-PCR, we showed that ADAR-1 could hypermutate adenosine residues in HTLV-2. STLV-3 hypermutation was obtained without using 3DI-PCR, suggesting a higher mutation frequency for this virus. Detailed analysis of the dinucleotide editing context showed preferences for 5' ArA and 5' UrA. In conclusion, the present observations demonstrate that ADAR-1 massively edits HTLV-2 and STLV-3 retroviruses in vitro, but probably remains a rare phenomenon in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22993189      PMCID: PMC4091295          DOI: 10.1099/vir.0.045146-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  37 in total

Review 1.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  HTLV-2 APH-2 expression is correlated with proviral load but APH-2 does not promote lymphocytosis.

Authors:  Estelle Douceron; Zhanna Kaidarova; Paola Miyazato; Masao Matsuoka; Edward L Murphy; Renaud Mahieux
Journal:  J Infect Dis       Date:  2011-11-07       Impact factor: 5.226

3.  Human T-cell lymphotropic virus type 3: complete nucleotide sequence and characterization of the human tax3 protein.

Authors:  Sara Calattini; Sébastien Alain Chevalier; Renan Duprez; Philippe Afonso; Alain Froment; Antoine Gessain; Renaud Mahieux
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

4.  Generalized and localized biased hypermutation affecting the matrix gene of a measles virus strain that causes subacute sclerosing panencephalitis.

Authors:  T C Wong; M Ayata; A Hirano; Y Yoshikawa; H Tsuruoka; K Yamanouchi
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

Review 5.  Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses.

Authors:  J P Slattery; G Franchini; A Gessain
Journal:  Genome Res       Date:  1999-06       Impact factor: 9.043

6.  RED2, a brain-specific member of the RNA-specific adenosine deaminase family.

Authors:  T Melcher; S Maas; A Herb; R Sprengel; M Higuchi; P H Seeburg
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

7.  Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations).

Authors:  P Rueda; B García-Barreno; J A Melero
Journal:  Virology       Date:  1994-02       Impact factor: 3.616

8.  Double-stranded RNA adenosine deaminases enhance expression of human immunodeficiency virus type 1 proteins.

Authors:  Angsana Phuphuakrat; Romchat Kraiwong; Chompunuch Boonarkart; Darat Lauhakirti; Tun-Hou Lee; Prasert Auewarakul
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

9.  Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes.

Authors:  Y Li; J C Kappes; J A Conway; R W Price; G M Shaw; B H Hahn
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

10.  Genomic organization and chromosomal location of the human dsRNA adenosine deaminase gene: the enzyme for glutamate-activated ion channel RNA editing.

Authors:  Y Wang; Y Zeng; J M Murray; K Nishikura
Journal:  J Mol Biol       Date:  1995-11-24       Impact factor: 5.469

View more
  10 in total

Review 1.  Mutations in components of antiviral or microbial defense as a basis for breast cancer.

Authors:  Bernard Friedenson
Journal:  Funct Integr Genomics       Date:  2013-09-21       Impact factor: 3.674

Review 2.  To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes.

Authors:  Melody M H Li; Margaret R MacDonald; Charles M Rice
Journal:  Trends Cell Biol       Date:  2015-03-03       Impact factor: 20.808

3.  ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity.

Authors:  Anne Cachat; Sandrine Alais; Sébastien Alain Chevalier; Chloé Journo; Floriane Fusil; Hélène Dutartre; Adrien Boniface; Nga Ling Ko; Antoine Gessain; François-Loïc Cosset; Rodolphe Suspène; Jean-Pierre Vartanian; Renaud Mahieux
Journal:  Retrovirology       Date:  2014-11-12       Impact factor: 4.602

Review 4.  Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs.

Authors:  Carl R Walkley; Jin Billy Li
Journal:  Genome Biol       Date:  2017-10-30       Impact factor: 13.583

5.  Spontaneous Mutations in HIV-1 Gag, Protease, RT p66 in the First Replication Cycle and How They Appear: Insights from an In Vitro Assay on Mutation Rates and Types.

Authors:  Joshua Yi Yeo; Darius Wen-Shuo Koh; Ping Yap; Ghin-Ray Goh; Samuel Ken-En Gan
Journal:  Int J Mol Sci       Date:  2020-12-31       Impact factor: 5.923

6.  PCIP-seq: simultaneous sequencing of integrated viral genomes and their insertion sites with long reads.

Authors:  Maria Artesi; Vincent Hahaut; Basiel Cole; Linos Vandekerckhove; Anne Van den Broeke; Keith Durkin; Laurens Lambrechts; Fereshteh Ashrafi; Ambroise Marçais; Olivier Hermine; Philip Griebel; Natasa Arsic; Frank van der Meer; Arsène Burny; Dominique Bron; Elettra Bianchi; Philippe Delvenne; Vincent Bours; Carole Charlier; Michel Georges
Journal:  Genome Biol       Date:  2021-04-06       Impact factor: 13.583

7.  Mutation rates and selection on synonymous mutations in SARS-CoV-2.

Authors:  Nicola De Maio; Conor R Walker; Yatish Turakhia; Robert Lanfear; Russell Corbett-Detig; Nick Goldman
Journal:  bioRxiv       Date:  2021-01-14

Review 8.  Equine infectious anemia virus in China.

Authors:  Hua-Nan Wang; Dan Rao; Xian-Qiu Fu; Ming-Ming Hu; Jian-Guo Dong
Journal:  Oncotarget       Date:  2017-08-21

9.  Evidence for host-dependent RNA editing in the transcriptome of SARS-CoV-2.

Authors:  Salvatore Di Giorgio; Filippo Martignano; Maria Gabriella Torcia; Giorgio Mattiuz; Silvestro G Conticello
Journal:  Sci Adv       Date:  2020-06-17       Impact factor: 14.957

Review 10.  HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology.

Authors:  Antoine Gessain; Réjane Rua; Edouard Betsem; Jocelyn Turpin; Renaud Mahieux
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.